<DOC>
	<DOCNO>NCT00182169</DOCNO>
	<brief_summary>Prospective randomize , placebo control , clinical trial evaluate effect human growth hormone supplementation compare placebo patient severe heart failure duration 6 month exercise capacity , heart function quality life</brief_summary>
	<brief_title>Evaluation Effect Human Recombinant Growth Hormone Patients With Advanced Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Individuals diagnosis CHF , NYHA functional class III IV symptom , EF &lt; 35 % estimate radionuclide angiography ( RNA ) 2D echo within last 6 month , 6 minute walk distance le 400 meter . Patients must stabilize “ CHF ” therapy time randomization . 1 . Exercise limited claudication , angina , neurological , pulmonary ( FEV1 &lt; 50 % ; FVC &lt; 50 % ) , musculoskeletal disease . 2 . Active known malignancy ; remission &lt; 5 year diagnosis malignancy ; patient recurrence malignancy withdrawn study . 3 . Current diabetes know retinopathy patient poorly control diabetes ( ie . fast glucose 13 mmol/l ) Type I diabetes mellitus . 4 . Any noncardiac condition substantially decrease survival . 5 . Significant valvular stenosis hypertrophic cardiomyopathy . 6 . Unable comply GH injection . 7 . Pregnancy woman child bear age use adequate contraceptive mean . 8 . Unstable angina , acute myocardial infarct , cardiac surgery , PTCA within 3 month . 9 . Cor pulmonale . 10 . Acute myocarditis . 11 . Known need cardiac surgery ( e.g. , valvular intervention , CABG , PTCA ) within next 6 month . 12 . Clinical hypothyroidism hyperthyroidism biochemical corroboration ( TSH &gt; 7 &lt; 0.2 ) screening . 13 . Patients need urgent heart transplant within next 6 month ( patient transplant list remain eligible ) . 14 . Sustained ventricular tachycardia ( last &gt; 30 second ) screen Holter . 15 . Significant liver disease ( INR &gt; 1.4 anticoagulant therapy ; AST , ALT , GGT , alkaline phosphatase &gt; 3X upper limit normal ; bilirubin &gt; 2X upper limit normal ) baseline . 16 . Failure give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2003</verification_date>
	<keyword>Severe heart failure</keyword>
	<keyword>Growth hormone</keyword>
	<keyword>exercise capacity</keyword>
	<keyword>quality life</keyword>
	<keyword>cardiac function</keyword>
</DOC>